USA v. Stinson et al

4:15-cr-40100Sdd16 de jun. de 2022

Abrir fonte

Texto completo

UNITED STATES DISTRICT COURT
DISTRICT OF SOUTH DAKOTA
SOUTHERN DIVISION
UNITED STATES OF AMERICA,
Plaintiff,
vs.
STEPHEN R. STINSON,
a/k/a Steven R. Stinson,
Defendant.
4:15-CR-40100-01-KES
ORDER DENYING MOTION FOR
RELIEF UNDER THE
FIRST STEP ACT
Defendant, Stephen R. Stinson, filed a motion for compassionate release
under 18 U.S.C. § 3582(c)(1)(A)(i).1 Docket 174. Plaintiff, the United States of
America, opposes the motion. Docket 179. For the following reasons, the
defendant’s motion for compassionate release is denied.
BACKGROUND
On March 22, 2017, Stinson pleaded guilty to conspiracy to distribute a
controlled substance in violation of 21 U.S.C. §§ 841(a)(1) and 846. Docket 115
¶ C; Docket 127. On June 12, 2017, the court sentenced Stinson to 262
months in custody, followed by eight years of supervised release. Docket 154;
Docket 157 at 2-3. His projected date of release is August 25, 2037. See Find
an Inmate., Fed. Bureau of Prisons, https://www.bop.gov/inmateloc/ (last
visited June 8, 2022).
Stinson is currently incarcerated at FCI Oakdale II, which is
1 The document filed by Stinson was captioned a “Motion for the Appointment
of Counsel Pursuant to 18 U.S.C. § 3006A.” Docket 174. Subsequently, the
document was categorized as a “Motion for Relief under FIRST STEP ACT
(Compassionate Release).” The court will construe the motion as a Motion for
Compassionate Release. See Docket 175.
Case 4:15-cr-40100-KES Document 183 Filed 06/16/22 Page 1 of 15 PageID #: <pageID>
2
encompassed by FCC Oakdale, a low security federal correctional complex. Id.;
FCI Oakdale II, Fed. Bureau of Prisons,
https://www.bop.gov/locations/institutions/oad/ (last visited June 8, 2022).
The total population at FCI Oakdale II is 1,150 persons. FCI Oakdale II.
Stinson is 52 years old. See Find an Inmate. In support of his motion for
relief, Stinson cites the COVID-19 pandemic and his diagnosed
hypothyroidism, which he claims places him in a high-risk category. Docket
174 at 1. He also points to his sentence enhancement under 21 U.S.C. § 851,
his participation in programs while incarcerated, and his healthy relationship
with his family as circumstances warranting release under the First Step Act.
Id. Stinson submitted an Inmate Request to the warden of FCC Oakdale
requesting compassionate release, which was received on December 13, 2021.
Docket 178 at 1. On December 30, 2021, the warden denied Stinson’s request
because Stinson had not served 50% of his sentence to qualify for home
confinement. Id. The United States filed a response opposing his motion on
February 1, 2022, claiming Stinson’s circumstances do not meet the high
standard under the statute and his motion should be denied. See Docket 179
at 8-11. Under Standing Order 20-06, the Federal Public Defender was
appointed as counsel, but the federal public defender’s office notified the court
that it did not intend to file a supplement in support of Stinson’s motion. See
Notice of Intent NOT to Supplement.
DISCUSSION
Because sentences are final judgments, a court ordinarily “may not
modify a term of imprisonment once it has been imposed[.]” 18 U.S.C.
Case 4:15-cr-40100-KES Document 183 Filed 06/16/22 Page 2 of 15 PageID #: <pageID>
3
§ 3582(c). In 2018, Congress passed the First Step Act (FSA). Pub. L. No. 115-
391, 132 Stat. 5194 (2018). In pertinent part, the FSA amends
18 U.S.C. § 3582(c)(1)(A) to permit incarcerated defendants in certain
circumstances to file motions with the court seeking compassionate release.
Compassionate release provides a narrow path for defendants with
“extraordinary and compelling reasons” to leave prison early.
18 U.S.C. § 3582(c)(1)(A)(i). Such a reduction in sentence must consider the 18
U.S.C. § 3553(a) sentencing factors and be consistent with applicable policy
statements issued by the Sentencing Commission. 18 U.S.C. § 3582(c)(1)(A).
The Sentencing Commission’s policy statement, which was adopted
before the FSA was enacted, requires both “extraordinary and compelling
reasons” to warrant a sentence reduction and that the defendant not pose a
danger to the safety of others. USSG § 1B1.13(1)-(2) (Nov. 2021). The burden to
establish that a sentence reduction is warranted under 18 U.S.C. § 3582(c)
rests with the defendant. See United States v. Jones, 836 F.3d 896, 899 (8th
Cir. 2016).
Stinson claims that his hypothyroidism and the COVID-19 pandemic has
provided an increased and “unnecessary” risk to his health and life and has
met the standard of “extraordinary and compelling reasons” required under 18
U.S.C. § 3582(c)(1)(A)(i). Docket 174 at 1-2. Stinson also cites his career
offender sentence enhancement under 21 U.S.C. § 851(a), his course work
while in custody, and his familial relationships as additional reasons to grant
his motion for compassionate release. Id.
Case 4:15-cr-40100-KES Document 183 Filed 06/16/22 Page 3 of 15 PageID #: <pageID>
4
I. 	Administrative Exhaustion
Previously, only the BOP Director had the authority to bring a
compassionate release motion on a defendant’s behalf. With the enactment of
the FSA, however, Congress has now permitted courts to grant compassionate
release on motions filed by defendants “after the defendant has fully exhausted
all administrative rights to appeal a failure of the Bureau of Prisons to bring a
motion on the defendant’s behalf or the lapse of 30 days from the receipt of
such a request by the warden of the defendant’s facility, whichever is
earlier . . . .” 18 U.S.C. § 3582(c)(1)(A).
As noted above, Stinson filed an Inmate Request to Staff form for
consideration of compassionate release, which was denied by the FCC Oakdale
warden on December 30, 2021. Docket 178 at 1. Having presented his request
to the warden and being denied, and hearing no objection from the United
States, the court will presume Stinson has satisfied the administrative
exhaustion requirement and will review the matter on the merits.2
II. 	Extraordinary and Compelling Reasons
The Sentencing Commission was directed by Congress to describe what
“should be considered extraordinary and compelling reasons” for
compassionate release and fashion “the criteria to be applied and a list of
specific examples.” See 28 U.S.C. § 994(t). The Sentencing Commission did so
by limiting “extraordinary and compelling reasons” to three categories. USSG
2 The warden's response states that if Stinson is not satisfied with the decision,
he may commence an appeal through the administrative remedy process within
20 days of receipt of the response. Docket 178 at 1. There is no indication that
Stinson appealed the decision administratively.
Case 4:15-cr-40100-KES Document 183 Filed 06/16/22 Page 4 of 15 PageID #: <pageID>
5
§ 1B1.13, cmt. n.1(A)-(C). The three categories apply to a defendant’s (1)
serious physical medical condition or cognitive impairment, terminal illness, or
deterioration of physical or mental health because of the aging process, (2)
advanced age and deteriorating health in combination with the amount of time
served, and (3) compelling family circumstances. Id. A fourth catch-all category
also exists for an “extraordinary and compelling reason other than, or in
combination with, the reasons described in subdivisions (A) through (C)” as
determined by the BOP. USSG § 1B1.13, cmt. n.1(D).
The court has detailed the governing law and the analysis it uses when
confronted with a compassionate release motion in many previous orders. E.g.,
United States v. Shields, 3:07-CR-30106-01-KES, 2021 WL 765001, at *2-3
(D.S.D. Feb. 26, 2021); United States v. Muhs, 4:19-CR-40023-02-KES, 2021
WL 534517, at *2-3 (D.S.D. Feb. 12, 2021); United States v. Adame, 4:18-CR-
40117-05-KES, 2020 WL 7212096, at *2-3 (D.S.D. Dec. 7, 2020); United States
v. Nyuon, 4:12-CR-40017-01-KES, 2020 WL 7029873, at *2-3 (D.S.D. Nov. 30,
2020). The court has assumed the policy statements still apply to
compassionate release motions brought under the FSA and utilizes USSG
§ 1B.13, Notes 1(A)-(D) to guide its analysis. See, e.g., Muhs, 2021 WL 534517,
at *3.
Stinson primarily contends that his hypothyroidism amidst the global
COVID-19 pandemic, the current conditions of FCI Oakland II, his
participation in coursework while incarcerated, and his positive relationship
with his family satisfy the standard of “extraordinary and compelling reasons”
under 18 U.S.C. § 3582(c)(1)(A)(i). See generally Docket 174. He also contends
Case 4:15-cr-40100-KES Document 183 Filed 06/16/22 Page 5 of 15 PageID #: <pageID>
6
that his sentence enhancement under 18 U.S.C. § 851 is no longer relevant
because the crime it was applied to occurred when he was involved in a gang
that he has since departed. Id. As a result, the court will analyze his
circumstances under the medical conditions category, USSG § 1B1.13 Note
1(A), the age category, USSG § 1B1.13 Note 1(B), and the catch-all provision,
USSG § 1B1.13 Note 1(D).
A. 	Medical Conditions Category, Note 1(A)
As relevant here, the medical conditions category applies when the
defendant is suffering from a serious physical or medical condition that
substantially diminishes his ability to provide self-care within a correctional
facility and from which he is not expected to recover. USSG § 1B1.13
cmt. n.1(A)(i)-(ii).
COVID-19 appears to pose a particular risk for individuals with certain
existing health conditions. The Centers for Disease Control and Prevention
(CDC) updated its current understanding of these risks. People with Certain
Medical Conditions, Ctrs. for Disease Control & Prevention (May 2, 2022),
https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-
with-medical-conditions.html. The CDC states individuals with the following
conditions are more likely to become very sick with COVID-19: cancer or
having a history of cancer, chronic kidney disease, chronic liver disease (such
as alcohol-related liver disease, non-alcoholic fatty liver disease, autoimmune
hepatitis, and cirrhosis), chronic lung diseases (including moderate to severe
asthma, bronchiectasis, bronchopulmonary dysplasia, chronic obstructive
pulmonary disease, emphysema, chronic bronchitis, interstitial lung disease,
Case 4:15-cr-40100-KES Document 183 Filed 06/16/22 Page 6 of 15 PageID #: <pageID>
7
idiopathy pulmonary fibrosis, pulmonary embolism, and pulmonary
hypertension), cystic fibrosis, dementia or other neurological conditions,
diabetes (type 1 or type 2), having certain disabilities (such as ADHD, cerebral
palsy, birth defects, intellectual and developmental disabilities, learning
disabilities, spinal cord injuries, or Down syndrome), heart conditions (such as
heart failure, coronary artery disease, cardiomyopathies, or hypertension), HIV
infection, immunocompromised state (having chemotherapy or a solid organ
transplant), mental health conditions (having mood disorders, including
depression, and schizophrenia spectrum disorders), being overweight or obese,
partaking in little or no physical activity, pregnancy, sickle cell disease or
thalassemia, being a current or former smoker, having a solid organ or blood
stem cell transplant, stroke or cerebrovascular disease, substance use
disorders (such as alcohol, opioid, or cocaine use disorder), and tuberculosis.
Id.
In his motion, Stinson did not cite additional health conditions other
than hypothyroidism, which he claims places him at a high risk of a severe
COVID-19 infection. Docket 174. As of May 2, 2022, the CDC has not listed
hypothyroidism as an underlying medical condition that exposes an individual
to a greater risk of COVID-19. See People with Certain Medical Conditions.
The court has reviewed the medical records in this case. Stinson’s
records list current ailments as hypothyroidism, an unspecified basal cell
carcinoma, a family history of melanoma, and a form of secondary syphilis.
Docket 176 at 47-48, 118-119. As of December 31, 2021, Stinson was taking
Levothyroxine for his hypothyroidism, doxycycline hyclate to treat skin lesions,
Case 4:15-cr-40100-KES Document 183 Filed 06/16/22 Page 7 of 15 PageID #: <pageID>
8
and Ibuprofen as needed for pain following the removal of a basal cell
carcinoma on December 13, 2021. Id. at 4, 18-19, 53. He is currently not
prescribed medication for the secondary form of syphilis. See id.
Stinson was diagnosed with hypothyroidism at an unknown time, and
his condition has remained stable throughout his stay with the BOP. Docket
176 at 100. During a clinic visit on February 24, 2020, his Thyroid-Stimulating
Hormone (TSH) levels were consistently low, so his physician considered
stopping his use of levothyroxine. Id. at 96-99. Throughout his time in the
BOP, Stinson’s dosage of levothyroxine has been managed and adjusted as
needed in conjunction with his TSH levels. Id. at 7, 9, 22-24, 31, 36, 93-97, 99-
101, 107-109, 111, 140, 145-146, 150, 153, 178, 193, 195, 197. This court
has previously held that hypothyroidism does not constitute an extraordinary
and compelling reason to justify an early release. See United States v. Kenefick,
No. 5:19-CR-50058-01-KES, 2022 WL 1295898, at *4 (D.S.D. Apr. 13, 2022).
Additionally, there is no indication from Stinson’s medical records that his
hypothyroidism is not sufficiently managed by his medication and the medical
staff at FCI Oakdale II.
The medical records also show Stinson had complained of a “spot” on his
left shoulder during a few clinic visits. Docket 176 at 11, 15, 18, 22. After a
skin biopsy was obtained, medical staff diagnosed it as a superficial basal cell
carcinoma on August 4, 2021. Id. at 11-15. The carcinoma was removed
without issue on December 13, 2021. See id. at 3. The status of the carcinoma
following its removal is unknown except that Stinson was scheduled to have
his sutures removed on January 3, 2022. Id. at 1.
Case 4:15-cr-40100-KES Document 183 Filed 06/16/22 Page 8 of 15 PageID #: <pageID>
9
Even though basal cell carcinoma is a type of skin cancer, very rarely
does it spread to nearby lymph nodes and other areas of the body. See
generally Basal Cell Carcinoma, Mayo Clinic,
https://www.mayoclinic.org/diseases-conditions/basal-cell-
carcinoma/symptoms-causes/syc-20354187 (last visited June 8, 2022).
Additionally, Stinson’s provider noted that basal cell carcinomas are “very
common, least likely to spread, easier to treat, [and] slow-growing.” Docket 176
at 11. Lastly, although Stinson has a history of “flares” from a secondary form
of syphilis, he has not had a reactive test since 2018 and is in remission.
Docket 176 at 26, 148.
The court has required a more particularized showing of a risk of serious
illness from COVID-19 when evaluating compassionate release motions. After
reviewing Stinson’s medical records, the court is not convinced that his health
conditions prevent him from obtaining sufficient medical care in a correctional
facility setting. In sum, the court does not believe his medical conditions
amount to extraordinary and compelling circumstances.
Additionally, the COVID-19 pandemic alone is insufficient to warrant an
early release. The BOP has made significant changes to correctional operations
since the pandemic started in early 2020. See COVID-19 Coronavirus, Fed.
Bureau of Prisons, https://www.bop.gov/coronavirus/ (last visited June 8,
2022). These include sanitary and safety measures, restrictions on movement,
and visitation restrictions, among others. Id. The BOP has also transferred
many thousands of inmates to home confinement. See id. From March 26,
2020, to the present, 43,072 inmates have been placed in home confinement.
Case 4:15-cr-40100-KES Document 183 Filed 06/16/22 Page 9 of 15 PageID #: <pageID>
10
Id. These measures have led to a dramatic decrease in the total BOP
population, which has increased opportunities for social distancing while
reducing the strain on BOP resources.
The court believes Stinson’s medical conditions are well-managed at FCI
Oakdale II. The facility is engaged in appropriate efforts to protect inmates
against the spread of COVID-19, and the facility acts to treat any inmate who
does contract COVID-19. To date, the facility has had 2 deaths resulting from a
COVID-19 infection, and 714 inmates have recovered. See COVID-19
Coronavirus. According to Stinson’s medical records, he has been tested at
least twice, with both tests being negative. Docket 176 at 47. This persuades
the court that FCI Oakdale II has acted appropriately to treat inmates who do
contract COVID-19. The court believes the facility will continue to appropriately
treat inmates who may become infected.
The BOP’s vaccination program for staff and inmates is another
protective measure warranting consideration in this stage of the COVID-19
pandemic. The BOP has implemented a COVID-19 vaccination plan to protect
inmates and staff and limit the transmission of COVID-19 within the facilities.
See COVID-19 Coronavirus. As of June 8, 2022, 320,077 doses have been
administered systemwide. Id. At FCC Oakdale, 258 staff and 1971 inmates
were fully inoculated as of June 8, 2022.3 Id. Stinson has received the two
primary doses of the Pfizer COVID-19 vaccine, but it appears he is not up to
3 Additional booster shots are not reflected in the data. See COVID-19
Coronavirus.
Case 4:15-cr-40100-KES Document 183 Filed 06/16/22 Page 10 of 15 PageID #: <pageID>
11
date with his COVID-19 vaccines.4 See Docket 176 at 52. The medical records
do not allude to whether Stinson has received or been offered a booster
vaccine. See id. The BOP affirms that “inmates have also been offered booster
shots in accordance with CDC guidance.”5 See COVID-19 Coronavirus. The
court encourages Stinson to obtain his booster shots for him to be up to date
with his COVID-19 vaccines and achieve additional protection against the
virus.
Moreover, the BOP’s efforts to limit the spread of COVID-19 and protect
inmates appear to be working. As of June 8, 2022, the BOP reported that 157
federal inmates had confirmed positive test results for COVID-19 nationwide.
See COVID-19 Coronavirus. There are currently over 139,500 federal inmates in
BOP-managed facilities. Id.
Considering the above, the court finds that Stinson’s circumstances do
not clear the high bar necessary to warrant compassionate release for
4 The CDC states that a person is up to date with their COVID-19 vaccines
when they “have received all doses in the primary series and all boosters
recommended for you, when eligible.” See Stay Up to Date with Your COVID-19
Vaccines, Ctrs. for Disease Control & Prevention (May 24, 2022),
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html.
An individual is eligible for their first Pfizer-BioNTech booster vaccine “at least
5 months after the final dose in the primary series[.]” See COVID-19 Vaccine
Boosters, Ctrs. For Disease Control & Prevention (May 24, 2022),
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/booster-shot.html.
Adults over 50 years old are eligible for their second booster “at least 4 months
after the 1st booster[.]” Id.
5 The BOP released guidance on the rollout of COVID-19 vaccines. See COVID-
19 Vaccine Guidance Federal Bureau of Prisons Clinical Guidance, Fed. Bureau
of Prisons (Feb. 25, 2022),
https://www.bop.gov/resources/pdfs/covid_19_vaccine_guidance_v17.pdf.
Inmates who received the Pfizer-BioNTech COVID-19 vaccine as their primary
vaccination series may receive a booster dose at least “five months after the
second primary series dose.” Id. at 21.
Case 4:15-cr-40100-KES Document 183 Filed 06/16/22 Page 11 of 15 PageID #: <pageID>
12
“extraordinary and compelling reasons” under 18 U.S.C. § 3582(c)(1)(A)(i).
B. 	Age Category, Note 1(B)
Under the First Step Act, the defendant must be (i) at least 65 years old;
(ii) experiencing a serious deterioration in physical or mental health because of
the aging process; and (iii) has served at least 10 years or 75 percent of his or
her term of imprisonment, whichever is less. See USSG § 1B1.13, cmt. n.1(B).
Stinson is 52 years old and has only served approximately 31.5% of his
sentence. See Find an Inmate. Thus, this category does not apply to him. See
id.; Docket 176 at 361.
C. 	Catch-all Category, Note 1(D)
The catch-all category in Note 1(D) does not result in a different outcome.
This category allows for release if there are extraordinary and compelling
reasons other than, or in combination with, those identified in 1(A) through
1(C). USSG § 1B1.13, cmt. n.1(D). Stinson claims that the § 851 enhancement
due to his criminal history and involvement in a gang is no longer applicable to
his sentence as he has since disassociated himself from the gang. Docket 174
at 1.
The court concludes that the enhancement was applied appropriately.
On March 7, 2017, the government filed an information pursuant to 21 U.S.C.
§ 851(b) notifying Stinson of its intention to seek an increased punishment due
to Stinson’s prior conviction of a felony drug offense in 2011. Docket 114. The
statute requires the defendant to affirm or deny whether he was previously
convicted of the alleged felony drug offense before a sentence is imposed. See
Case 4:15-cr-40100-KES Document 183 Filed 06/16/22 Page 12 of 15 PageID #: <pageID>
13
21 U.S.C. § 851. Also, in the plea agreement signed by Stinson, there is a
provision stating that Stinson agreed not to challenge the enhanced penalty
based on his prior conviction. Docket 115 ¶ J. Subsequently, Stinson had a
change of plea hearing on June 12, 2017, and he presented no concerns
regarding the sentence enhancement. See Docket 127 at 2. Further, the
Presentence Investigation Report (PSR) also listed the prior conviction when
calculating his criminal history score. Docket 137 ¶ 84. No objections to the
PSR were filed, and both parties affirmed the conviction at sentencing. Dockets
138, 154. As a result of the enhancement, his guideline range was 262-327
months’ custody. Docket 137 ¶¶ 80, 81. Stinson was sentenced at the bottom
end of the range to 262 months’ custody on June 12, 2017. Docket 157 at 2.
Although Stinson notes that he has disaffiliated with the gang, the
enhancement was correctly applied. Docket 174 at 1. Stinson’s time for appeal
of his judgment of conviction has expired. A judgment was filed on June 12,
2017, and more than 14 days have passed since the filing. See Fed. R. App. P.
Rule 4(b)(1)(A)(i).
Stinson also reports that he received his GED and has been an avid
participant in BOP education and vocational courses. Docket 174 at 1; Docket
176 at 355-361. Although the court applauds Stinson’s determination to live a
productive and crime-free life upon release, this is not a sufficient factor to
favor an early release.
Finally, Stinson indicates that he has maintained a relationship with his
family while in prison and currently has plans to stay with his nephew upon
release. Docket 174 at 1. While the court acknowledges that he has a stable
Case 4:15-cr-40100-KES Document 183 Filed 06/16/22 Page 13 of 15 PageID #: <pageID>
14
plan upon release, it is still not enough to support compassionate release.
The court finds that the circumstances cited by Stinson regarding his
§ 851 enhancement, his participation in educational programming, and his
positive relationship with his family do not warrant a reduction in sentence
under the catch-all category, Note 1(D).
III. 	Sentencing Factors of § 3553(a)
The 3553(a) sentencing factors further show that compassionate release
is not warranted. Stinson pleaded guilty to conspiracy to distribute a controlled
substance. Docket 127. Various individuals told law enforcement that Stinson
would sell methamphetamine to them and other individuals after he had
arrived in Mitchell, South Dakota in 2014. Docket 137 ¶ 18. His girlfriend at
the time and co-defendant in this case told law enforcement that Stinson would
receive packages at the residence containing methamphetamine and
occasionally marijuana. Id. Others involved in the conspiracy stated that
Stinson had developed a plan to have people in Fresno, California, send
packages of methamphetamine, marijuana, and hydrocodone pills to various
addresses in Mitchell. Id. ¶ 19. While the PSR states that the exact amount is
unknown, under USSG § 2D1.1(a)(5), when a defendant is accountable for at
least 150 grams but less than 500 grams of methamphetamine, the Base
Offense Level is 32. Id. ¶ 27.
The total offense level calculated was 34, and Stinson was in criminal
history category VI. Id. ¶¶ 36, 53. Stinson is categorized as a career offender
due to his prior felony drug offense conviction under USSG § 4B1.1(b). Id. § 53.
Case 4:15-cr-40100-KES Document 183 Filed 06/16/22 Page 14 of 15 PageID #: <pageID>
15
As a result, the United States pursued an increased punishment under 21
U.S.C. § 851(a). Id. ¶ 84; Docket 114; Docket 115 § J. Stinson’s guideline range
was 262 to 327 months in custody, and he faced a mandatory minimum
sentence of 10 years. Docket 137 at ¶¶ 80-82. The court sentenced Stinson at
the bottom end of the guideline range to 262 months in custody. Docket 154 at
2; Docket 157 at 2. After careful consideration, the court concludes Stinson’s
sentence of 262 months continues to be appropriate for the seriousness of the
crime to which he pleaded guilty.
CONCLUSION
Stinson has failed to satisfy the extraordinary and compelling reason
standard. Thus, it is
ORDERED that the defendant’s motion for relief under the First Step Act
(Docket 174) is denied.
Dated June 16, 2022.
BY THE COURT:
/s/ Karen E. Schreier
KAREN E. SCHREIER
UNITED STATES DISTRICT JUDGE
Case 4:15-cr-40100-KES Document 183 Filed 06/16/22 Page 15 of 15 PageID #: <pageID>

Continue sua pesquisa no ChatGPT ou Claude

Conecte o Omnilex para pesquisar o corpus jurídico pelo seu assistente de IA.